Savolitinib for Treating Gastric Cancer and Esophagogastric Junction Adenocarcinoma Patients

Clinical trial NCT04923932 · COMPLETED

Trial details

NCT number: NCT04923932
Sponsor: Hutchison Medipharma Limited
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gastric Cancer Esophagogastric Junction Disorder

Start date: 2021-07-27
Primary completion: 2026-04-21
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.